Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)—A Delphi Consensus Statement

Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)—A Delphi Consensus Statement

PURPOSE: The purpose of this study is to establish consensus among experts on outcomes and methods to be used in clinical trials to assess adverse effects of anti-glaucomatous eye drops. DESIGN: Modified Delphi method. METHODS: Clinical experts from Europe, North America, South America, the Middle E...

Full description

Bibliographic Details
Main Authors: Arita, R. (Author), Azuara-Blanco, A. (Author), Cvenkel, B. (Author), de Paiva, C.S (Author), Gazzard, G. (Author), Hedengran, A. (Author), Heegaard, S. (Author), Kolko, M. (Author), Petrovski, G. (Author), Prokosch-Willing, V. (Author), Thein, A.-S (Author), Utheim, T.P (Author), Virgili, G. (Author)
Format: Article
Language:English
Published: Elsevier Inc. 2022
Subjects:
adverse effects
consensus
Delphi Study
Glaucoma
ocular surface
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items